Search

Author/Creator Hulot, Jean‐Sebastien

3. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology. (20th October 2020)

Authors:
Pudil, Radek; Mueller, Christian; Čelutkienė, Jelena; Henriksen, Peter A.; Lenihan, Dan; Dent, Susan; Barac, Ana; Stanway, Susanna; Moslehi, Javid; Suter, Thomas M.; Ky, Bonnie; Štěrba, Martin; Cardinale, Daniela; Cohen‐Solal, Alain; Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Bergler‐Klein, ...
Journal:
European journal of heart failure
Issue:
Volume 22:Number 11(2020)
Page Start:
1966
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). (14th January 2022)

Authors:
de Boer, Rudolf A.; Heymans, Stephane; Backs, Johannes; Carrier, Lucie; Coats, Andrew J.S.; Dimmeler, Stefanie; Eschenhagen, Thomas; Filippatos, Gerasimos; Gepstein, Lior; Hulot, Jean‐Sebastien; Knöll, Ralph; Kupatt, Christian; Linke, Wolfgang A.; Seidman, Christine E.; Tocchetti, C. Gabriele; va...
Journal:
European journal of heart failure
Issue:
Volume 24:Number 3(2022)
Page Start:
406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗